Reference (year), total sample, n
|
Imaging modality + FOV
|
Age of total sample and MAWOC
|
Prevalence of calcification and MAWC
|
Most common type of calcification in PWC
|
Gender-age Comparison in PWC
|
Current study (2022), n = 9,533
|
Full size of DPR
|
18–93, MAWOC: 39.24± y/o
|
35.8% (n = 3418), AWC: 44.34±
|
OSHC (10.3%)
|
Females related to age and gender
|
Maia et al.(2021) [21], n = 1,176
|
Full size of DPR
|
>60 years, MAWOC: 67.47 y/o
|
43%, AWC: No report
|
CSHTC (23.6%)
|
Females
|
Akgunlu (2019) [22], n = 4,263
|
Full size of DPR
|
6–89 years, MAWOC: 27.44±
|
6.4% (n: 270), AWC: 40.37± y/o
|
Tonsillolith (2.5%)
|
No significant difference between genders; related to increasing age
|
Ribeiro et al.(2018) [23], n = 2,375
|
Full size of DPR
|
3–90 y/o, MAWOC: No report
|
19.7% (n: 420), AWC: No report
|
OSHC (13.1%)
|
Not gender related; related with increasing age
|
Bayramov et al. (2022) [24], n = 1,566
|
Maxillofacial CBCT
|
18–80 y/o, MAWOC: No report
|
24.9 % (n: 390), AWC: 47.3±
|
Tonsillolith (53.6%)
|
Different rates across age/gender groups depending on STC type
|
Elhadidy et al.(2021) [25], n = 417
|
Large FOV CBCT
|
10–80 y/o, MAWOC: No report
|
22.54% (n: 94), MAWC: 42.07±
|
OSHC (16.55%)
|
Higher in males; different rates across age groups depending on STC type
|
Yalcin and Ararat (2020) [26], n = 1,557
|
16 × 5, 16 × 9, 16 × 16 cm
|
11–84 y/o, MAWOC: 35.25±
|
33.4% (n: 520), MAWC: 44.22± y/o
|
Tonsillolith (18.8%)
|
Predominant in males, significantly higher in older patients
|
Missias et al. (2018), [27] n = 1,000
|
MX-FOV 57.2% MD-FOV 60.6% MM-FOV 76.8%
|
<30–≥ 60 y/o, AWOC: No report
|
62.6% (n: 626), MAWC: No report
|
Tonsillolith OSHC
|
No significant association with age or gender
|
Patil et al. (2017) [28], n = 624
|
Maxillofacial CBCT
|
Age range: MAWOC: 43.74± y/o
|
25.48% (n: 159), MAWC: 48.64± y/o
|
Arteriosclerosis (45.91%)
|
Predominant in females and advanced age
|
Wells and Adam (2011) [29], n = 308
|
MM-FOV MD-FOV Full 13.2 c m
|
7–86 years, MAWOC: 47.5± y/o
|
34.75% (n: 107), MAWC: 59.5
|
CTC (32.3%)
|
Predominance in females; calcifications found in older patients
|